of outcome assessment in shunted patients. Neurosurgery. (2005) 57:S40–
52. doi: 10.1227/01.NEU.0000168187.01077.2F
5. Kahlon B, Sjunnesson J, Rehncrona S. Long-term outcome
in patients with suspected normal pressure hydrocephalus.
Neurosurgery. (2007) 60:327–32. doi: 10.1227/01.NEU.0000249273.415
69.6E
6. Wikkelso C, Hellstrom P, Klinge PM, Tans JT, European I NPHMSG. The
European iNPH Multicentre Study on the predictive values of resistance
to CSF outflow and the CSF Tap Test in patients with idiopathic normal
pressure hydrocephalus. J Neurol Neurosurg Psychiatry. (2013) 84:562–
8. doi: 10.1136/jnnp-2012-303314
1. Ames RH. Ventriculo-peritoneal shunts in the management of hydrocephalus.
J Neurosurg. (1967) 27:525–9. doi: 10.3171/jns.1967.27.6.0525
2. Nulsen FE, Spitz EB. Treatment of hydrocephalus by direct shunt from
ventricle to jugular vain. Surg Forum. (1952) 2:399–403.
3. Hakim S. Hydraulic and mechanical mis-matching of valve shunts used in the
treatment of hydrocephalus: the need for a servo-valve shunt. Dev Med Child
Neurol. (1973) 15:646–53. doi: 10.1111/j.1469-8749.1973.tb05175.x
4. Klinge P, Marmarou A, Bergsneider M, Relkin N, Black PM. Outcome
of shunting in idiopathic normal-pressure hydrocephalus and the value
Frontiers in Neurology | www.frontiersin.org
12
January 2022 | Volume 12 | Article 798488
Yamada et al.
V-P Shunt and Valve Pressure
7. Williams MA, Relkin NR. Diagnosis and management of
idiopathic normal-pressure hydrocephalus. Neurol Clin Pract. (2013)
3:375–85. doi: 10.1212/CPJ.0b013e3182a78f6b
8. Ziebell M, Wetterslev J, Tisell M, Gluud C, Juhler M. Flow-regulated versus
differential pressure-regulated shunt valves for adult patients with normal
pressure hydrocephalus. Cochrane Database Syst Rev. (2013) 5:CD009706.
doi: 10.1002/14651858.CD009706.pub2
9. Saehle T, Farahmand D, Eide PK, Tisell M, Wikkelso C. A randomized
controlled dual-center trial on shunt complications in idiopathic normalpressure hydrocephalus treated with gradually reduced or “fixed” pressure
valve settings. J Neurosurg. (2014) 121:1257–63. doi: 10.3171/2014.7.JNS14283
10. Kazui H, Miyajima M, Mori E, Ishikawa M, Investigators S.
Lumboperitoneal shunt surgery for idiopathic normal pressure hydrocephalus
(SINPHONI-2): an open-label randomised trial. Lancet Neurol. (2015)
14:585–94. doi: 10.1016/S1474-4422(15)00046-0
11. Miyajima M, Kazui H, Mori E, Ishikawa M, Sinphoni-Investigators
OBOT. One-year outcome in patients with idiopathic normal-pressure
hydrocephalus: comparison of lumboperitoneal shunt to ventriculoperitoneal
shunt. J Neurosurg. (2016) 125:1483–92. doi: 10.3171/2015.10.JNS151894
12. Miyake H. Shunt devices for the treatment of adult hydrocephalus: recent
progress and characteristics. Neurol Med Chir (Tokyo). (2016) 56:274–
83. doi: 10.2176/nmc.ra.2015-0282
13. Williams MA, Malm J. Diagnosis and treatment of idiopathic normal
pressure hydrocephalus. Continuum (Minneap Minn). (2016) 22:579–
99. doi: 10.1212/CON.0000000000000305
14. Yamada S, Ishikawa M, Miyajima M, Nakajima M, Atsuchi M, Kimura
T, et al. Timed up and go test at tap test and shunt surgery in
idiopathic normal pressure hydrocephalus. Neurol Clin Pract. (2017) 7:98–
108. doi: 10.1212/CPJ.0000000000000334
15. Yamada S, Kimura T, Jingami N, Atsuchi M, Hirai O, Tokuda T, et al. Disability
risk or unimproved symptoms following shunt surgery in patients with
idiopathic normal-pressure hydrocephalus: post hoc analysis of SINPHONI-2.
J Neurosurg. (2017) 126:2002–9. doi: 10.3171/2016.5.JNS16377
16. Marmarou A, Bergsneider M, Relkin N, Klinge P, Black PM. Development
of guidelines for idiopathic normal-pressure hydrocephalus: introduction.
Neurosurgery. (2005) 57:S1–3. doi: 10.1227/01.NEU.0000168188.25559.0E
17. Marmarou A, Black P, Bergsneider M, Klinge P, Relkin N, International
NPHCG. Guidelines for management of idiopathic normal pressure
hydrocephalus: progress to date. Acta Neurochir Suppl. (2005) 95:237–
40. doi: 10.1007/3-211-32318-X_48
18. Ishikawa M, Hashimoto M, Kuwana N, Mori E, Miyake H, Wachi A, et al.
Guidelines for management of idiopathic normal pressure hydrocephalus.
Neurol Med Chir (Tokyo). (2008) 48(Suppl.):S1–23. doi: 10.2176/nmc.48.S1
19. Mori E, Ishikawa M, Kato T, Kazui H, Miyake H, Miyajima M,
et al. Guidelines for management of idiopathic normal pressure
hydrocephalus: second edition. Neurol Med Chir (Tokyo). (2012)
52:775–809. doi: 10.2176/nmc.52.775
20. Halperin JJ, Kurlan R, Schwalb JM, Cusimano MD, Gronseth G, Gloss
D. Practice guideline: idiopathic normal pressure hydrocephalus:
response to shunting and predictors of response: report of the guideline
development, dissemination, and implementation subcommittee
of the American Academy of Neurology. Neurology. (2015)
85:2063–71. doi: 10.1212/WNL.0000000000002193
21. Nakajima M, Yamada S, Miyajima M, Ishii K, Kuriyama N, Kazui
H, et al. Guidelines for Management of Idiopathic Normal Pressure
Hydrocephalus (Third Edition): endorsed by the Japanese Society of
Normal Pressure Hydrocephalus. Neurol Med Chir (Tokyo). (2021) 61:63–
97. doi: 10.2176/nmc.st.2020-0292
22. Stolze H, Kuhtz-Buschbeck JP, Drucke H, Johnk K, Illert M, Deuschl G.
Comparative analysis of the gait disorder of normal pressure hydrocephalus
and Parkinson’s disease. J Neurol Neurosurg Psychiatry. (2001) 70:289–
97. doi: 10.1136/jnnp.70.3.289
23. Ishikawa M, Yamada S, Yamamoto K. Agreement study on gait
assessment using a video-assisted rating method in patients with
idiopathic normal-pressure hydrocephalus. PLoS ONE. (2019)
14:e0224202. doi: 10.1371/journal.pone.0224202
24. Yamada S, Aoyagi Y, Ishikawa M, Yamaguchi M, Yamamoto K, Nozaki
K. Gait assessment using three-dimensional acceleration of the trunk in
Frontiers in Neurology | www.frontiersin.org
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
13
idiopathic normal pressure hydrocephalus. Front Aging Neurosci. (2021)
13:653964. doi: 10.3389/fnagi.2021.653964
Black PM. Idiopathic normal-pressure hydrocephalus. Results of shunting
in 62 patients. J Neurosurg. (1980) 52:371–7. doi: 10.3171/jns.1980.52.
3.0371
Krauss JK, Droste DW, Vach W, Regel JP, Orszagh M, Borremans JJ, et al.
Cerebrospinal fluid shunting in idiopathic normal-pressure hydrocephalus
of the elderly: effect of periventricular and deep white matter lesions.
Neurosurgery. (1996) 39:292–9. doi: 10.1097/00006123-199608000-00011
Boon AJ, Tans JT, Delwel EJ, Egeler-Peerdeman SM, Hanlo PW,
Wurzer JA, et al. Dutch normal pressure hydrocephalus study: baseline
characteristics with emphasis on clinical findings. Eur J Neurol. (1997)
4:39–47. doi: 10.1111/j.1468-1331.1997.tb00297.x
Eide PK. Intracranial pressure parameters in idiopathic normal pressure
hydrocephalus patients treated with ventriculo-peritoneal shunts. Acta
Neurochir (Wien). (2006) 148:21–9. doi: 10.1007/s00701-005-0654-8
Hellstrom P, Klinge P, Tans J, Wikkelso C. A new scale for assessment
of severity and outcome in iNPH. Acta Neurol Scand. (2012) 126:229–
37. doi: 10.1111/j.1600-0404.2012.01677.x
Ishikawa M, Yamada S, Yamamoto K, Aoyagi Y. Gait analysis in a component
timed-up-and-go test using a smartphone application. J Neurol Sci. (2019)
398:45–9. doi: 10.1016/j.jns.2019.01.023
Ishikawa M, Yamada S, Yamamoto K. Early and delayed assessments of
quantitative gait measures to improve the tap test as a predictor of shunt
effectiveness in idiopathic normal pressure hydrocephalus. Fluids Barriers
CNS. (2016) 13:20. doi: 10.1186/s12987-016-0044-z
Nakajima M, Yamada S, Miyajima M, Kawamura K, Akiba C, Kazui H, et
al. Tap test can predict cognitive improvement in patients with iNPH-results
from the multicenter prospective studies SINPHONI-1 and−2. Front Neurol.
(2021) 12:769216. doi: 10.3389/fneur.2021.769216
Wikkelso C, Andersson H, Blomstrand C, Lindqvist G, Svendsen
P. Normal pressure hydrocephalus. Predictive value of the
cerebrospinal fluid tap-test. Acta Neurol Scand. (1986) 73:566–
73. doi: 10.1111/j.1600-0404.1986.tb04601.x
Ishikawa M, Oowaki H, Matsumoto A, Suzuki T, Furuse M, Nishida N. (2010).
Clinical significance of cerebrospinal fluid tap test and magnetic resonance
imaging/computed tomography findings of tight high convexity in patients
with possible idiopathic normal pressure hydrocephalus. Neurol Med Chir
(Tokyo). 50:119–23. doi: 10.2176/nmc.50.119
Ishikawa M, Hashimoto M, Mori E, Kuwana N, Kazui H. The value
of the cerebrospinal fluid tap test for predicting shunt effectiveness in
idiopathic normal pressure hydrocephalus. Fluids Barriers CNS. (2012)
9:1. doi: 10.1186/2045-8118-9-1
Mihalj M, Dolic K, Kolic K, Ledenko V. CSF tap test–obsolete or appropriate
test for predicting shunt responsiveness? a systemic review. J Neurol Sci.
(2016) 362:78–84. doi: 10.1016/j.jns.2016.01.028
Yamada S, Ishikawa M, Miyajima M, Atsuchi M, Kimura T, Kazui H, et al.
Disease duration: the key to accurate CSF tap test in iNPH. Acta Neurol Scand.
(2017) 135:189–96. doi: 10.1111/ane.12580
Thakur SK, Serulle Y, Miskin NP, Rusinek H, Golomb J, George AE. Lumbar
puncture test in normal pressure hydrocephalus: does the volume of csf
removed affect the response to tap? AJNR Am J Neuroradiol. (2017) 38:1456–
60. doi: 10.3174/ajnr.A5187
Schniepp R, Trabold R, Romagna A, Akrami F, Hesselbarth K, Wuehr
M, et al. Walking assessment after lumbar puncture in normal-pressure
hydrocephalus: a delayed improvement over 3 days. J Neurosurg. (2017)
126:148–57. doi: 10.3171/2015.12.JNS151663
Yamada S, Aoyagi Y, Yamamoto K, Ishikawa M. Quantitative evaluation of
gait disturbance on an instrumented timed up-and-go test. Aging Dis. (2019)
10:23–36. doi: 10.14336/AD.2018.0426
Yamada S, Ishikawa M, Nozaki K. Exploring mechanisms of ventricular
enlargement in idiopathic normal pressure hydrocephalus: a role of
cerebrospinal fluid dynamics and motile cilia. Fluids Barriers CNS. (2021)
18:20. doi: 10.1186/s12987-021-00243-6
Yamada S, Ishikawa M, Yamamoto K. Optimal diagnostic indices for
idiopathic normal pressure hydrocephalus based on the 3D quantitative
volumetric analysis for the cerebral ventricle and subarachnoid space. AJNR
Am J Neuroradiol. (2015) 36:2262–9. doi: 10.3174/ajnr.A4440
January 2022 | Volume 12 | Article 798488
Yamada et al.
V-P Shunt and Valve Pressure
60. Wan KR, Toy JA, Wolfe R, Danks A. Factors affecting the
accuracy of ventricular catheter placement. J Clin Neurosci. (2011)
18:485–8. doi: 10.1016/j.jocn.2010.06.018
61. Jeremiah KJ, Cherry CL, Wan KR, Toy JA, Wolfe R, Danks RA. Choice
of valve type and poor ventricular catheter placement: Modifiable factors
associated with ventriculoperitoneal shunt failure. J Clin Neurosci. (2016)
27:95–8. doi: 10.1016/j.jocn.2015.07.026
62. Wilson, T. J., Mccoy, K. E., Al-Holou, W. N., Molina, S. L., Smyth,
M. D., and Sullivan, S. E. (2016). Comparison of the accuracy and
proximal shunt failure rate of freehand placement versus intraoperative
guidance in parietooccipital ventricular catheter placement. Neurosurg Focus
41:E10. doi: 10.3171/2016.5.FOCUS16159
63. Huyette DR, Turnbow BJ, Kaufman C, Vaslow DF, Whiting BB, Oh MY.
Accuracy of the freehand pass technique for ventriculostomy catheter
placement: retrospective assessment using computed tomography scans. J
Neurosurg. (2008) 108:88–91. doi: 10.3171/JNS/2008/108/01/0088
64. Lind CR, Tsai AM, Lind CJ, Law AJ. Ventricular catheter placement accuracy
in non-stereotactic shunt surgery for hydrocephalus. J Clin Neurosci. (2009)
16:918–20. doi: 10.1016/j.jocn.2008.09.015
65. Wilson TJ, Stetler WR, Al-Holou WN, Sullivan SE. Comparison of the
accuracy of ventricular catheter placement using freehand placement,
ultrasonic guidance, and stereotactic neuronavigation. J Neurosurg. (2013)
119:66–70. doi: 10.3171/2012.11.JNS111384
66. Yamada S, Ishikawa M, Yamamoto K. Utility of preoperative simulation for
ventricular catheter placement via a parieto-occipital approach in normalpressure hydrocephalus. Oper Neurosurg (Hagerstown). (2019) 16:647–
57. doi: 10.1093/ons/opy193
67. Gautschi OP, Smoll NR, Kotowski M, Schatlo B, Tosic M, Stimec B, et al.
Non-assisted versus neuro-navigated and XperCT-guided external ventricular
catheter placement: a comparative cadaver study. Acta Neurochir (Wien).
(2014) 156:777–85. doi: 10.1007/s00701-014-2026-8
68. Nesvick CL, Khan NR, Mehta GU, Klimo P. Jr. Image guidance
in ventricular cerebrospinal fluid shunt catheter placement:
a systematic review and meta-analysis. Neurosurgery. (2015)
77:321–31. doi: 10.1227/NEU.0000000000000849
69. Pollack IF, Albright AL, Adelson PD. A randomized, controlled study
of a programmable shunt valve versus a conventional valve for patients
with hydrocephalus. Hakim-Medos Investigator Group. Neurosurgery. (1999)
45:1399–408. doi: 10.1097/00006123-199912000-00026
70. Ringel F, Schramm J, Meyer B. Comparison of programmable shunt
valves vs standard valves for communicating hydrocephalus of adults:
a retrospective analysis of 407 patients. Surg Neurol. (2005) 63:36–
41. doi: 10.1016/j.surneu.2004.03.015
71. Kameda M, Yamada S, Atsuchi M, Kimura T, Kazui H, Miyajima M, et al.
Cost-effectiveness analysis of shunt surgery for idiopathic normal pressure
hydrocephalus based on the SINPHONI and SINPHONI-2 trials. Acta
Neurochir (Wien). (2017) 159:995–1003. doi: 10.1007/s00701-017-3115-2
72. Czosnyka
Z,
Pickard
JD,
Czosnyka
M.
Hydrodynamic
properties of the Certas hydrocephalus shunt. J Neurosurg
Pediatr.
(2013)
11:198–204.
doi:
10.3171/2012.10.PEDS
12239
73. Czosnyka Z, Czosnyka M, Pickard JD. Hydrodynamic performance of a new
siphon preventing device: the SiphonGuard. J Neurol Neurosurg Psychiatry.
(1999) 66:408–9. doi: 10.1136/jnnp.66.3.408a
74. Miyake H, Kajimoto Y, Tsuji M, Ukita T, Tucker A, Ohmura T. Development
of a quick reference table for setting programmable pressure valves in patients
with idiopathic normal pressure hydrocephalus. Neurol Med Chir. (2008)
48:427–32. doi: 10.2176/nmc.48.427
75. Miyake H, Kajimoto Y, Murai H, Nomura S, Ono S, Okamoto Y, et
al. Assessment of a quick reference table algorithm for determining
initial postoperative pressure settings of programmable pressure valves
in patients with idiopathic normal pressure hydrocephalus: SINPHONI
subanalysis. Neurosurgery. (2012) 71:722–8. doi: 10.1227/NEU.0b013e3182
60fef7
76. Farahmand D, Sæhle T, Eide PK, Tisell M, Hellström P, Wikkelsö C. A
double-blind randomized trial on the clinical effect of different shunt valve
settings in idiopathic normal pressure hydrocephalus. J Neurosurg. (2016)
124:359–67. doi: 10.3171/2015.1.JNS141301
43. Toma AK, Holl E, Kitchen ND, Watkins LD. Evans’ index revisited: the need
for an alternative in normal pressure hydrocephalus. Neurosurgery. (2011)
68:939–44. doi: 10.1227/NEU.0b013e318208f5e0
44. Virhammar J, Laurell K, Cesarini KG, Larsson EM. Preoperative
prognostic value of MRI findings in 108 patients with idiopathic
normal pressure hydrocephalus. AJNR Am J Neuroradiol. (2014)
35:2311–8. doi: 10.3174/ajnr.A4046
45. Yamada S, Ishikawa M, Iwamuro Y, Yamamoto K. Choroidal fissure acts as an
overflow device in cerebrospinal fluid drainage: morphological comparison
between idiopathic and secondary normal-pressure hydrocephalus. Sci Rep.
(2016) 6:39070. doi: 10.1038/srep39070
46. Jaraj D, Rabiei K, Marlow T, Jensen C, Skoog I, Wikkelso C. Estimated
ventricle size using Evans index: reference values from a population-based
sample. Eur J Neurol. (2017) 24:468–74. doi: 10.1111/ene.13226
47. Yamada S, Ishikawa M, Yamamoto K. Fluid distribution pattern in
adult-onset congenital, idiopathic, and secondary normal-pressure
hydrocephalus: implications for clinical care. Front Neurol. (2017)
8:583. doi: 10.3389/fneur.2017.00583
48. Shereen XYS, Aravin Kumar A, Audrey JL, Tan Yu Tung LO, Christine
L, Sumeet K, et al. The impact of multimorbidity burden, frailty risk
scoring, and 3-directional morphological indices vs. testing for CSF
responsiveness in normal pressure hydrocephalus. Front Neurosci. (2021)
15:751145. doi: 10.3389/fnins.2021.751145
49. Hashimoto M, Ishikawa M, Mori E, Kuwana N. Diagnosis of
idiopathic normal pressure hydrocephalus is supported by MRI-based
scheme: a prospective cohort study. Cerebrospinal Fluid Res. (2010)
7:18. doi: 10.1186/1743-8454-7-18
50. Ishikawa M, Oowaki H, Takezawa M, Takenaka T, Yamada S,
Yamamoto K, et al. Disproportionately enlarged subarachnoid
space hydrocephalus in idiopathic normal-pressure hydrocephalus
and its implication in pathogenesis. Acta Neurochir Suppl. (2016)
122:287–90. doi: 10.1007/978-3-319-22533-3_57
51. Ishii K, Kanda T, Harada A, Miyamoto N, Kawaguchi T, Shimada
K, et al. Clinical impact of the callosal angle in the diagnosis of
idiopathic normal pressure hydrocephalus. Eur Radiol. (2008) 18:2678–
83. doi: 10.1007/s00330-008-1044-4
52. Yamada S, Ishikawa M, Yamamoto K. Comparison of CSF distribution
between idiopathic normal pressure hydrocephalus and Alzheimer’s
Disease. AJNR Am J Neuroradiol. (2016) 37:1249–55. doi: 10.3174/ajnr.
A4695
53. Virhammar J, Laurell K, Cesarini KG, Larsson EM. Increase in callosal
angle and decrease in ventricular volume after shunt surgery in patients
with idiopathic normal pressure hydrocephalus. J Neurosurg. (2018) 130:130–
5. doi: 10.3171/2017.8.JNS17547
54. Yamada S, Ishikawa M, Yamaguchi M, Yamamoto K. Longitudinal
morphological changes during recovery from brain deformation due
to idiopathic normal pressure hydrocephalus after ventriculoperitoneal
shunt surgery. Sci Rep. (2019) 9:17318. doi: 10.1038/s41598-01953888-7
55. Kuriyama N, Miyajima M, Nakajima M, Kurosawa M, Fukushima W,
Watanabe Y, et al. Nationwide hospital-based survey of idiopathic normal
pressure hydrocephalus in Japan: Epidemiological and clinical characteristics.
Brain Behav. (2017) 7:e00635. doi: 10.1002/brb3.635
56. Nakajima M, Miyajima M, Ogino I, Akiba C, Kawamura K, Kurosawa M, et
al. Shunt intervention for possible idiopathic normal pressure hydrocephalus
improves patient outcomes: a nationwide hospital-based survey in Japan.
Front Neurol. (2018) 9:421. doi: 10.3389/fneur.2018.00421
57. Ishikawa M, Yamada S, Miyajima M, Kazui H, Mori E. Improvement in the
long-term care burden after surgical treatment of patients with idiopathic
normal pressure hydrocephalus: a supplementary study. Sci Rep. (2021)
11:11732. doi: 10.1038/s41598-021-90911-2
58. Janson CG, Romanova LG, Rudser KD, Haines SJ. Improvement in
clinical outcomes following optimal targeting of brain ventricular
catheters
with
intraoperative
imaging.
Neurosurg.
(2014)
120:684–96. doi: 10.3171/2013.8.JNS13250
59. Kitagaki H, Mori E, Ishii K, Yamaji S, Hirono N, Imamura T. CSF spaces in
idiopathic normal pressure hydrocephalus: morphology and volumetry. AJNR
Am J Neuroradiol. (1998) 19:1277–84.
Frontiers in Neurology | www.frontiersin.org
14
January 2022 | Volume 12 | Article 798488
Yamada et al.
V-P Shunt and Valve Pressure
77. Yamada S, Ishikawa M, Yamamoto K, Ino T, Kimura T, Kobayashi S,
et al. Aneurysm location and clipping versus coiling for development of
secondary normal-pressure hydrocephalus after aneurysmal subarachnoid
hemorrhage: Japanese Stroke DataBank. J Neurosurg. (2015) 123:1555–
61. doi: 10.3171/2015.1.JNS142761
78. Hebb AO, Cusimano MD Idiopathic normal pressure hydrocephalus: a
systematic review of diagnosis and outcome. Neurosurgery. (2001) 49:1166–
84. doi: 10.1227/00006123-200111000-00028
79. Toma AK, Papadopoulos MC, Stapleton S, Kitchen ND, Watkins
LD. Systematic review of the outcome of shunt surgery in idiopathic
normal-pressure hydrocephalus. Acta Neurochir (Wien). (2013)
155:1977–80. doi: 10.1007/s00701-013-1835-5
80. Merkler AE, Ch’ang J, Parker WE, Murthy SB, Kamel H. The rate of
complications after ventriculoperitoneal shunt surgery. World Neurosurg.
(2017) 98:654–8. doi: 10.1016/j.wneu.2016.10.136
81. Andren K, Wikkelso C, Hellstrom P, Tullberg M, Jaraj D. Early
shunt surgery improves survival in idiopathic normal pressure
hydrocephalus. Eur J Neurol. (2021) 28:1153–9. doi: 10.1111/ene.1
4671
82. Larsson J, Israelsson H, Eklund A, Lundin-Olsson L, Malm J. Falls and fear
of falling in shunted idiopathic normal pressure hydrocephalus-the idiopathic
normal pressure hydrocephalus comorbidity and risk factors associated with
hydrocephalus study. Neurosurgery. (2021) 89:122–8. doi: 10.1093/neuros/nya
b094
Corporation for 4 years, beginning 2019; from the G-7 Scholarship Foundation
in 2020; and from Taiju Life Social Welfare Foundation in 2020. He received a
speaker’s honoraria from Integra Japan, Fujifilm Medical Systems, Medtronic, Inc.,
and Nihon Medi-Physics Co., Ltd. MN received a speaker’s honoraria from Integra
Japan, Janssen Pharmaceutical K.K., and Medtronic, Inc. These were unrelated to
the submitted work. KN has received grants from the Japan Agency for Medical
Research and Development (AMED), a KAKENHI grant from the Japan Society
for the Promotion of Science, and speaker’s honoraria from Pfizer, Japan Inc., and
Daiichi Sankyo Co., Ltd. These were unrelated to the submitted work.
The remaining author declares that the research was conducted in the absence of
any commercial or financial relationships that could be construed as a potential
conflict of interest.
Publisher’s Note: All claims expressed in this article are solely those of the authors
and do not necessarily represent those of their affiliated organizations, or those of
the publisher, the editors and the reviewers. Any product that may be evaluated in
this article, or claim that may be made by its manufacturer, is not guaranteed or
endorsed by the publisher.
Copyright © 2022 Yamada, Ishikawa, Nakajima and Nozaki. This is an open-access
article distributed under the terms of the Creative Commons Attribution License (CC
BY). The use, distribution or reproduction in other forums is permitted, provided
the original author(s) and the copyright owner(s) are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Conflict of Interest: SY has received research grants from the Japan Society for
the Promotion of Science, KAKENHI for 3 years, beginning 2021; from Fujifilm
Frontiers in Neurology | www.frontiersin.org
15
January 2022 | Volume 12 | Article 798488
...